Epithelial cells antibodies

Introduction to Epithelial cells

Epithelial cells are fundamental building blocks that form the protective and functional linings of organs and tissues throughout the body. These versatile cells create barriers on surfaces such as the skin, respiratory tract, digestive system, and blood vessels, playing crucial roles in absorption, secretion, and sensation. Their ability to regenerate and adapt makes them essential for maintaining homeostasis and defending against environmental threats and pathogens. In the realm of biomedical research, understanding the behavior and regulation of epithelial cells is pivotal for uncovering the mechanisms behind various diseases, including cancers, inflammatory disorders, and infections. Antibodies targeting specific epithelial cell markers are invaluable tools that enable scientists to visualize, isolate, and manipulate these cells with precision. By leveraging these specialized antibodies, researchers can advance their studies on epithelial cell functions, interactions, and pathologies, driving innovations in diagnostics and therapeutic interventions.

Contents:

1. Epithelial cells Biomarkers
2. Important Mechanisms

Epithelial cells biomarkers

Protein Name	Gene Name	Function
E-cadherin	CDH1	Cell-cell adhesion
Cytokeratin 8	KRT8	Cytoskeletal structure
EpCAM	EpCAM	Cell adhesion and proliferation
Mucin 1	MUC1	Barrier and signaling
EGFR	EGFR	Growth signaling
Claudin-1	CLDN1	Tight junctions
Desmoglein-3	DSG3	Cell adhesion
OVOL1	OVOL1	Cell differentiation
P-cadherin	CDH3	Cell adhesion
Cytokeratin 19	KRT19	Cytoskeletal structure
HER2	ERBB2	Growth signaling
ZO-1	TJP1	Tight junctions
Integrin beta-4	ITGB4	Cell adhesion
S100A4	S100A4	Cell motility
β-catenin	CTNNB1	Wnt signaling and adhesion
MUC16	MUC16	Tumor marker
CD44	CD44	Cell adhesion and migration
TROP2	TACSTD2	Cell proliferation
FOXA1	FOXA1	Transcription factor
GATA3	GATA3	Transcription factor

Important Mechanisms

Epithelial Barrier Function and Tight Junctions

Epithelial barrier function is a fundamental aspect of epithelial cell biology, essential for maintaining the integrity and selective permeability of tissues. Epithelial cells line various surfaces and cavities in the body, including the skin, gastrointestinal tract, and respiratory system, serving as the first line of defense against pathogens, toxins, and mechanical stress. Tight junctions, specialized protein complexes located at the apical region of epithelial cells, play a critical role in establishing and regulating this barrier. They control the paracellular pathway, restricting the free passage of ions and molecules between cells, thereby maintaining distinct internal environments necessary for proper cellular function. Disruptions in tight junction integrity can lead to increased permeability, contributing to a range of pathological conditions such as inflammatory bowel disease, asthma, and cancer metastasis. Research in this sub-area focuses on understanding the molecular composition of tight junctions, the signaling pathways that regulate their assembly and disassembly, and the mechanisms by which epithelial barriers respond to physiological and pathological stimuli. Advances in this field hold significant implications for developing therapeutic strategies aimed at restoring barrier function in disease states and improving drug delivery across epithelial barriers.

Epithelial-Mesenchymal Transition (EMT)

Epithelial-Mesenchymal Transition (EMT) is a dynamic and reversible biological process wherein epithelial cells lose their characteristic cell polarity and cell-cell adhesion properties to acquire a mesenchymal phenotype, marked by enhanced migratory capacity, invasiveness, and resistance to apoptosis. EMT plays a pivotal role in various physiological processes, including embryonic development, wound healing, and tissue regeneration. However, its dysregulation is implicated in numerous pathological conditions, most notably in cancer progression and metastasis. During EMT, epithelial cells undergo extensive transcriptional reprogramming driven by key signaling pathways such as TGF-β, Wnt, and Notch. This leads to the downregulation of epithelial markers like E-cadherin and the upregulation of mesenchymal markers such as N-cadherin and vimentin. Understanding the molecular mechanisms governing EMT is crucial for developing targeted therapies to inhibit cancer metastasis and overcome therapeutic resistance. Additionally, EMT is being explored in the context of fibrosis and immune regulation, highlighting its broad relevance in health and disease. Current research in this sub-area employs advanced techniques like single-cell RNA sequencing and live-cell imaging to unravel the complexities of EMT and its implications in various biological contexts.